Skip to content

Clinical trials

Expanded access Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Expanded access Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available12
Available5
Approved for marketing4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AbbVie2
Astellas Pharma Global Development, Inc.2
Celgene2
Agios Pharmaceuticals, Inc.1
Barbara Ann Karmanos Cancer Institute1
Christopher Dvorak1
Emory University1
Genelux Corporation1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute21
Myelodysplastic Syndromes6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Hematologic Neoplasms3
Leukemia3
Lymphoma3
Congenital Abnormalities2
Graft vs Host Disease2
Immunologic Deficiency Syndromes2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.